Cheminformatics-Based Drug Design Approach for Identification of Inhibitors Targeting the Characteristic Residues of MMP-13 Hemopexin Domain

Roopa Kothapalli, Asif M. Khan, Basappa et al. · 2010

Read Cheminformatics-Based Drug Design Approach for Identification of Inhibitors Targeting the Characteristic Residues of MMP-13 Hemopexin Domain by Roopa Kothapalli, Asif M. Khan, Basappa et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0012494.txt.

Description

Roopa Kothapalli, Asif Khan, Basappa and colleagues used computer design to find blockers of a cartilage-chewing enzyme, in a 2010 PLOS ONE paper. The enzyme MMP-13 cuts type II collagen, the main protein of joint cartilage, and it is active in osteoarthritis and rheumatoid arthritis but not in healthy adult tissue. That selectivity makes it a tempting drug target.

The team aimed at a side region of the enzyme, its hemopexin domain, whose special residues differ from sister enzymes. Blocking there could spare related enzymes and cut side effects. Computer-first design narrows thousands of candidates to a testable few, saving years of bench screening for arthritis drug hunters.

Catalog record

CREATORRoopa Kothapalli, Asif M. Khan, Basappa et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE29 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012494

Browse the full library · About the Tower of Babel